| Literature DB >> 33602674 |
Allon N Friedman1, Lee M Kaplan2, Carel W le Roux3, Philip R Schauer4.
Abstract
Obesity is a leading public health problem that currently affects over 650 million individuals worldwide. Although interest in the adverse effects of obesity has grown exponentially in recent years, less attention has been given to studying its management in individuals with CKD. This relatively unexplored area should be considered a high priority because of the rapid growth and high prevalence of obesity in the CKD population, its broad impact on health and outcomes, and its modifiable nature. This article begins to lay the groundwork in this field by providing a comprehensive overview that critically evaluates the available evidence related to obesity and kidney disease, identifies important gaps in our knowledge base, and integrates recent insights in the pathophysiology of obesity to help provide a way forward in establishing guidelines as a basis for managing obesity in CKD. Finally, the article includes a kidney-centric algorithm for management of obesity that can be used in clinical practice.Entities:
Keywords: GLP-1; arteriovenous access; bariatric surgery; chronic kidney disease; diabetes; kidney transplantation; metabolic surgery; obesity; quality of life; weight loss
Year: 2021 PMID: 33602674 PMCID: PMC8017542 DOI: 10.1681/ASN.2020101472
Source DB: PubMed Journal: J Am Soc Nephrol ISSN: 1046-6673 Impact factor: 10.121